Investigating the impact of OCT transporter genotype on metformin-induced vitamin B12 deficiency
Metformin is the first-line therapy for the treatment of Type 2 Diabetes Mellitus (T2DM) and is the most widely prescribed anti-diabetic drug in the world. A common and potentially hazardous side-effect of metformin treatment is vitamin B12 deficiency. OCT1 (SLC22A1) and OCT2 (SLC22A2) are highly po...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Liverpool
2016
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.706764 |